Global Epigenetics Market Comprehensive Study Explores Huge Growth In Future, 2020-2026|Diagenode s.a.; Active Motif; Zymo Research; Thermo Fisher Scientific Inc.; Cellcentric; Syndax

Global epigenetics market is expected to register a healthy CAGR of 14.63% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the significant advancements in technologies of epigenetics as well as rising investments and expenditure incurred to further develop the field of epigenetics.

Epigenetics Market Research Report Will Help To Take Informed Decisions, Understand Opportunities, Plan Effective Business Strategies, Plan New Projects, Analyze Drivers And Restraints And Give Vision On The Forecast. Report Is An Specialist And Broad Research Report On The Major Regional Market Conditions, Concentrating On The United States, China, Europe, Japan, Southeast Asia, And India Regions.

Get Sample Copy Of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-epigenetics-market

Few of the major competitors currently working in the global epigenetics market are Illumina, Inc.; Merck KGaA; QIAGEN; F. Hoffmann-La Roche Ltd; Eisai Co., Ltd.; Novartis AG; Abcam plc; Diagenode s.a.; Active Motif; Zymo Research; Thermo Fisher Scientific Inc.; Cellcentric; Syndax; New England Biolabs; Epizyme, Inc.; Domainex; Agilent Technologies, Inc.; PerkinElmer Inc.; Bio-Rad Laboratories, Inc.; AsisChem Inc.; Enzo Life Sciences, Inc.; EpiGentek Group Inc.; BioVision Inc.; Bio-Techne; Promega Corporation; GeneTex, Inc. and Pacific Biosciences of California, Inc. among others.

Key Developments in the Market:

In May 2019, Souvien Therapeutics was established by Juvenescence, which will focus on development of innovative medicines for applications in neurodegenerative disorders with the help of targeting epigenetics in neurodegeneration. The company will focus on development of therapeutics to address the epigenetics mechanisms in neurodegenerations
In May 2018, Cellcentric announced that they had raised USD 26 million for the development of epigenetic based drug candidate for cancers till the stage of Phase 2B trials. The drug termed as, "CCS1477" has been evident to treat patients suffering from late-stage prostate cancer, being resistance against anti-androgen drugs. Cellcentric is aiming to increase its application of the drug candidate to more than just prostate cancer where the cancer is showing mutation signs of p300 and CBP proteins

Highlight points of the report:

1. CAGR values in the Global epigenetics market for the forecast period

2. Key trends in the market place

3.Global epigenetics market Major players and brands

4. Drivers and restrains of the market

5. Competitive landscape

6. Potential and niche segments/regions exhibiting promising growth

Get Detailed Table Of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-epigenetics-market

Segmentation: Global Epigenetics Market

By Product

Reagents
Antibody
Buffer
Histone
Magnetic Bead
Primer
Others
Kits & Assays
Bisulfite Conversion Kit
ChIP Sequencing Kit
Deep Sequencing Kit
Whole Genome Amplification Kit
RNA Sequencing Kit
Immunoprecipitation Kit
5-HMC & 5-MC Analysis Kit
Methyltransferase Assays
Histone Assays
Others
Instruments
Mass Spectrometers
Next-Generation Sequencers (NGS)
Quantitative Polymerase Chain Reaction (qPCRs)
Sonicators
Others
Enzymes
DNA Modifying Enzyme
DNA Ligases
DNA Polymerases
Others
Protein Modifying Enzyme
Acetylases
Methyltransferases
Others
RNA Modifying Enzyme
Reverse Transcriptase
RNA Ligases
Others
Services
Bioinformatics Tools

By Technology

DNA Methylation
Histone Methylation
Histone Acetylation
Large Non-Coding RNA
MicroRNA Modification
Chromatin Structures

By Application

Oncology
Solid Tumors
Liquid Tumors
Non-Oncology
Inflammatory Diseases
Metabolic Diseases
Infectious Diseases
Cardiovascular Diseases
Developmental Biology
Drug Discovery
Others

By End-Users

Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)

By Geography

North America
Europe
Asia-Pacific
South America
Middle East and Africa

Need more Information about Report Methodology @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-epigenetics-market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.